Back to 
Amundi
Amundi
TXG
Showing 5 of 18 quarters
Position history for Amundi's holdings in 10x Genomics, Inc.
No. Amundi exited its TXG (10x Genomics) position in Q3 2025. Its Q2 2025 13F listed 204,847 shares worth $2.7M. Amundi already held TXG in its Q2 2021 13F, the earliest on record, and held it in 16 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2M
Total Shares Change
-100,892
Quarter-by-Quarter History